Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13
TUESDAY, Sept. 19, 2023 (HealthDay News) — For children with sickle cell disease (SCD), the rates of invasive pneumococcal infection (IPD) have decreased since introduction of pneumococcal conjugate vaccines (PCVs), according to a study published onl…
Learn MoreCélulas madre modificadas genéticamente ofrecen esperanza contra la anemia de células falciformes
VIERNES, 1 de septiembre de 2023 (HealthDay News) — Un tipo de terapia génica que edita con precisión una parte clave del ADN podría ofrecer una nueva forma de tratar la anemia de células falciformes, una dolorosa condición hereditaria que afecta pr…
Learn MoreGene-Tweaked Stem Cells Offer Hope Against Sickle Cell Disease
THURSDAY, Aug. 31, 2023 (HealthDay News) — A type of gene therapy that precisely “edits” a key bit of DNA might offer a new way to treat sickle cell disease — a painful inherited condition that largely strikes Black children and adults.That’s accord…
Learn MoreSickle Cell Disease Highly Contributes to All-Cause Mortality
THURSDAY, July 20, 2023 (HealthDay News) — Globally, sickle cell disease provides a high contribution to all-cause mortality, especially among children younger than 5 years, according to a study published online June 15 in The Lancet Haematology.Azal…
Learn MoreMás evidencias de que una terapia genética podría curar la enfermedad de células falciformes
LUNES, 12 de junio de 2023 (HealthDay News) — Un ensayo clínico que intenta descubrir una cura para la enfermedad de células falciformes (o anemia drepanocítica) encontró que una nueva terapia genética es segura y exitosa en cuatro pacientes. Dos de …
Learn MoreMore Evidence Gene Therapy Might Cure Sickle Cell Disease
MONDAY, June 12, 2023 (HealthDay News) — A clinical trial that’s attempting to discover a cure for sickle cell disease has found a new gene therapy to be safe and successful in four patients.Two of the patients were treated at Cleveland Clinic Childr…
Learn MoreGene Therapy Not Cost-Effective for Sickle Cell by Conventional Measures
MONDAY, June 5, 2023 (HealthDay News) — For persons with sickle cell disease (SCD), gene therapy seems not to be cost-effective per conventional cost-effectiveness analysis (CEA) standards and can be equitable per distributional CEA (DCEA) standards,…
Learn MoreGene Therapy Not Cost-Effective for Sickle Cell by Conventional Measures
MONDAY, June 5, 2023 (HealthDay News) — For persons with sickle cell disease (SCD), gene therapy seems not to be cost-effective per conventional cost-effectiveness analysis (CEA) standards and can be equitable per distributional CEA (DCEA) standards,…
Learn MoreSickle Cell Gene Therapy Can Cure, But Costs Almost $3 Million. Who Will Pay?
WEDNESDAY, May 31, 2023 (HealthDay News) — An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether insurance companies will balk at the cost and deny coverage.On the surface, the gene ther…
Learn MoreSickle Cell Gene Therapy Can Cure, But Costs Almost $3 Million. Who Will Pay?
WEDNESDAY, May 31, 2023 (HealthDay News) — An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether insurance companies will balk at the cost and deny coverage.On the surface, the gene ther…
Learn More